Literature DB >> 8668679

Enhanced cellular uptake of oligonucleotides by EGF receptor-mediated endocytosis in A549 cells.

D Deshpande1, D Toledo-Velasquez, D Thakkar, W Liang, Y Rojanasakul.   

Abstract

PURPOSE: The goal of this study was to investigate the feasibility of utilizing epidermal growth factor (EGF) receptor-mediated endocytosis to enhance cellular uptake and targeting of oligonucleotides in epithelial cancer cells. To overcome the problem of endosomal entrappment associated with receptor-mediated delivery, we also examined the effects of two fusogenic peptides, polymyxin B and influenza HA2 peptide, for their capability to promote cytoplasmic delivery of oligonucleotides.
METHODS: A molecular conjugate consisting of EGF and poly-L-lysine (PL) was synthesized and complexed with 5' fluorescently-labeled oligonucleotide. Cellular uptake of the complex in presence or absence of the fusogenic peptides was monitored fluorometrically. Microscopic studies were performed to visualize the intracellular distribution of the oligonucleotide.
RESULTS: Cells treated with the complex exhibited intracellular fluorescence intensity significantly enhanced over free oligonucleotide-treated controls. The uptake of the complex was shown to occur via the EGF receptor-mediated pathway. Fluorescence microscopic studies revealed cellular internalization of the complex, however, the complex appeared to be accumulated in endocytic vesicles. Exposure of the cells to complex in presence of HA2 peptide and polymyxin B resulted in a more diffused intracellular fluorescence pattern and a corresponding increase in fluorescence intensity. These results are consistent with the known fusion and destabilizing activities of the peptides.
CONCLUSIONS: Since EGF receptors are overexpressed in many cancer cell types, the EGF-PL conjugate may potentially be used as an effective and selective delivery system to enhance uptake of oligonucleotides into cancer cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8668679     DOI: 10.1023/a:1016073132320

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  12 in total

1.  Antibody-targeted liposomes containing oligodeoxyribonucleotides complementary to viral RNA selectively inhibit viral replication.

Authors:  J P Leonetti; P Machy; G Degols; B Lebleu; L Leserman
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

Review 2.  The structure and function of the hemagglutinin membrane glycoprotein of influenza virus.

Authors:  D C Wiley; J J Skehel
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

3.  A spring-loaded mechanism for the conformational change of influenza hemagglutinin.

Authors:  C M Carr; P S Kim
Journal:  Cell       Date:  1993-05-21       Impact factor: 41.582

4.  Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer.

Authors:  D J Slamon; W Godolphin; L A Jones; J A Holt; S G Wong; D E Keith; W J Levin; S G Stuart; J Udove; A Ullrich
Journal:  Science       Date:  1989-05-12       Impact factor: 47.728

5.  Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin.

Authors:  T A Libermann; H R Nusbaum; N Razon; R Kris; I Lax; H Soreq; N Whittle; M D Waterfield; A Ullrich; J Schlessinger
Journal:  Nature       Date:  1985 Jan 10-18       Impact factor: 49.962

6.  Polyamidoamine cascade polymers mediate efficient transfection of cells in culture.

Authors:  J Haensler; F C Szoka
Journal:  Bioconjug Chem       Date:  1993 Sep-Oct       Impact factor: 4.774

7.  Cholesteryl-conjugated oligonucleotides: synthesis, properties, and activity as inhibitors of replication of human immunodeficiency virus in cell culture.

Authors:  R L Letsinger; G R Zhang; D K Sun; T Ikeuchi; P S Sarin
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

8.  Improved biological activity of antisense oligonucleotides conjugated to a fusogenic peptide.

Authors:  J P Bongartz; A M Aubertin; P G Milhaud; B Lebleu
Journal:  Nucleic Acids Res       Date:  1994-11-11       Impact factor: 16.971

9.  Biological activity of oligonucleotide-poly(L-lysine) conjugates: mechanism of cell uptake.

Authors:  J P Leonetti; G Degols; B Lebleu
Journal:  Bioconjug Chem       Date:  1990 Mar-Apr       Impact factor: 4.774

10.  Inhibition of leukaemia cell proliferation by folic acid-polylysine-mediated introduction of c-myb antisense oligodeoxynucleotides into HL-60 cells.

Authors:  G Citro; C Szczylik; P Ginobbi; G Zupi; B Calabretta
Journal:  Br J Cancer       Date:  1994-03       Impact factor: 7.640

View more
  4 in total

1.  Oligonucleotides tethered to a short polyguanylic acid stretch are targeted to macrophages: enhanced antiviral activity of a vesicular stomatitis virus-specific antisense oligonucleotide.

Authors:  V Prasad; S Hashim; A Mukhopadhyay; S K Basu; R P Roy
Journal:  Antimicrob Agents Chemother       Date:  1999-11       Impact factor: 5.191

2.  Efficient Gene Suppression by DNA/DNA Double-Stranded Oligonucleotide In Vivo.

Authors:  Yutaro Asami; Tetsuya Nagata; Kotaro Yoshioka; Taiki Kunieda; Kie Yoshida-Tanaka; C Frank Bennett; Punit P Seth; Takanori Yokota
Journal:  Mol Ther       Date:  2020-12-07       Impact factor: 11.454

Review 3.  Improving the endosomal escape of cell-penetrating peptides and their cargos: strategies and challenges.

Authors:  Alfredo Erazo-Oliveras; Nandhini Muthukrishnan; Ryan Baker; Ting-Yi Wang; Jean-Philippe Pellois
Journal:  Pharmaceuticals (Basel)       Date:  2012-11-01

Review 4.  Innovations in oligonucleotide drug delivery.

Authors:  Melanie A Lysik; Susanna Wu-Pong
Journal:  J Pharm Sci       Date:  2003-08       Impact factor: 3.534

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.